Your browser doesn't support javascript.
loading
Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
Honig, Lawrence S; Sabbagh, Marwan N; van Dyck, Christopher H; Sperling, Reisa A; Hersch, Steven; Matta, Andre; Giorgi, Luigi; Gee, Michelle; Kanekiyo, Michio; Li, David; Purcell, Derk; Dhadda, Shobha; Irizarry, Michael; Kramer, Lynn.
Afiliação
  • Honig LS; Columbia University Irving Medical Center, NYS Center of Excellence for Alzheimer's Disease, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Gertrude H. Sergievsky Center (PH19), & Department of Neurology, Columbia University Vagelos College of Physicians & Surgeons,
  • Sabbagh MN; Barrow Neurological Institute, Phoenix, AZ, 85013, USA.
  • van Dyck CH; Yale School of Medicine, New Haven, CT, USA.
  • Sperling RA; Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Hersch S; Eisai Inc., Nutley, NJ, USA.
  • Matta A; Eisai Inc., Nutley, NJ, USA.
  • Giorgi L; Eisai Co., Ltd, Hatfield, UK.
  • Gee M; Eisai Co., Ltd, Hatfield, UK.
  • Kanekiyo M; Eisai Inc., Nutley, NJ, USA.
  • Li D; Eisai Inc., Nutley, NJ, USA.
  • Purcell D; Clario, Philadelphia, PA, USA.
  • Dhadda S; Eisai Inc., Nutley, NJ, USA.
  • Irizarry M; Eisai Inc., Nutley, NJ, USA.
  • Kramer L; Eisai Inc., Nutley, NJ, USA.
Alzheimers Res Ther ; 16(1): 159, 2024 Jul 10.
Article em En | MEDLINE | ID: mdl-38987826
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Alzheimers Res Ther Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Alzheimers Res Ther Ano de publicação: 2024 Tipo de documento: Article